Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 103298, 11 pages
http://dx.doi.org/10.1155/2012/103298
Research Article

Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model

1Department of Urology, Weill Medical College of Cornell University, New York, NY 10065, USA
2Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
3Smith Institute of Urology, North Shore-Long Island Jewish Health System, New Hyde Park, NY 11042, USA

Received 1 October 2011; Accepted 14 November 2011

Academic Editor: Dirk Rades

Copyright © 2012 Eric C. Kauffman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Eric C. Kauffman, Huixian Liu, Michael J. Schwartz, and Douglas S. Scherr, “Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model,” Journal of Oncology, vol. 2012, Article ID 103298, 11 pages, 2012. https://doi.org/10.1155/2012/103298.